Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options
- PMID: 26233437
- DOI: 10.1007/s40266-015-0289-2
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options
Abstract
Clostridium difficile infection (CDI) is the most common cause of infectious diarrhea in healthcare settings. Along with antimicrobial exposure, advanced age has been shown to be a significant risk factor for the development and recurrence of, and mortality from, CDI. The substantial burden of CDI in the elderly may be related to frequent healthcare exposure, the necessity for more medications, altered intestinal microbiota, and complicated comorbidities. A diagnosis of CDI is based on evidence of toxin, or the C. difficile organism itself, in a stool sample in the presence of clinical signs and symptoms. Only symptomatic patients should be tested for CDI, and routine surveillance or repeat testing on asymptomatic patients as a test of cure is discouraged. Antibiotic discontinuation alone can improve or resolve CDI in some patients, and concomitant use of antibiotics is associated with decreased response to CDI treatment. Metronidazole, vancomycin, and fidaxomicin are the therapeutic agents currently available for CDI, with the selection of these agents being based on disease severity, history of recurrence, and cost. The recurrence rate after initial treatment is 20-30%. The first recurrence can be treated with the same therapeutic agent and, for subsequent recurrences, vancomycin in a tapered and/or pulsed regimen is recommended. Fecal microbiota transplantation has shown remarkable effectiveness for recurrent anti-refractory CDI, although caution is advised in treating immunocompromised hosts and those with toxic megacolon. C. difficile can be transmitted directly and indirectly via contact with patients or their environment; therefore, isolation precautions should be initiated at the first suspicion of CDI. C. difficile spores can survive for a long time on environmental surfaces, and the patient's room and all equipment used in the room should be disinfected. In order to manage CDI in the elderly, timely diagnosis, appropriate treatment based on severity of illness, and effective infection control are essential.
Similar articles
-
Clostridium difficile infection in older adults: a review and update on its management.Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Am J Geriatr Pharmacother. 2012. PMID: 22260856 Review.
-
[Individualized treatment strategies for Clostridium difficile infections].Internist (Berl). 2017 Jul;58(7):675-681. doi: 10.1007/s00108-017-0268-2. Internist (Berl). 2017. PMID: 28589214 Review. German.
-
Best strategies in recurrent or persistent Clostridium difficile infection.Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18. Surg Infect (Larchmt). 2011. PMID: 21767157 Review.
-
Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?Clin Microbiol Infect. 2012 Dec;18 Suppl 6:28-35. doi: 10.1111/1469-0691.12012. Clin Microbiol Infect. 2012. PMID: 23121552 Review.
-
Clostridium difficile infection in the elderly: an update on management.Clin Interv Aging. 2017 Oct 24;12:1799-1809. doi: 10.2147/CIA.S149089. eCollection 2017. Clin Interv Aging. 2017. PMID: 29123385 Free PMC article. Review.
Cited by
-
Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain.Adv Ther. 2018 Nov;35(11):1920-1934. doi: 10.1007/s12325-018-0813-y. Epub 2018 Oct 16. Adv Ther. 2018. PMID: 30328061 Free PMC article.
-
Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients.Sci Rep. 2016 Aug 11;6:31498. doi: 10.1038/srep31498. Sci Rep. 2016. PMID: 27510591 Free PMC article.
-
The Gut Microbiome as a Therapeutic Target for Cognitive Impairment.J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1242-1250. doi: 10.1093/gerona/glz281. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31811292 Free PMC article. Review.
-
Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series.Clin Drug Investig. 2017 Jul;37(7):699-703. doi: 10.1007/s40261-017-0524-1. Clin Drug Investig. 2017. PMID: 28386820
-
Nutrition and the gut microbiome in the elderly.Gut Microbes. 2017 Mar 4;8(2):82-97. doi: 10.1080/19490976.2016.1256525. Epub 2016 Nov 3. Gut Microbes. 2017. PMID: 27808595 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical